Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Option Care Health ( (OPCH) ) just unveiled an announcement.
On March 30, 2026, Option Care Health, Inc. amended its Amended and Restated First Lien Credit Agreement by entering into a Fifth Amendment with Bank of America, N.A. as administrative agent and certain subsidiaries and lenders. The amendment increases the company’s revolving credit commitments by $450 million, bringing total revolving commitments under the facility to $850 million, expanding its available liquidity and financial flexibility for corporate and operational needs.
The expanded revolving credit capacity, secured through the latest amendment to the first lien credit facility, signals continued lender support and enhances Option Care Health’s ability to manage working capital and fund strategic initiatives. This larger credit line may strengthen the company’s balance sheet resilience and positioning in the infusion therapy market, with potential implications for future investments, acquisitions, or other capital deployment decisions.
The most recent analyst rating on (OPCH) stock is a Hold with a $29.00 price target. To see the full list of analyst forecasts on Option Care Health stock, see the OPCH Stock Forecast page.
Spark’s Take on OPCH Stock
According to Spark, TipRanks’ AI Analyst, OPCH is a Outperform.
The score is driven primarily by solid fundamentals (strong multi-year growth and profitability, with some recent margin and cash-flow cooling) and supportive technical trend strength. Reaffirmed 2026 guidance and planned cash-flow improvement help offset near-term headwinds (Stelara/biosimilar impact, payer pressure) and a premium P/E valuation.
To see Spark’s full report on OPCH stock, click here.
More about Option Care Health
Option Care Health, Inc. operates in the healthcare sector as a provider of infusion therapy services, delivering complex pharmaceutical treatments outside of traditional hospital settings. The company focuses on coordinating care through its network and leveraging financing arrangements such as its first lien credit facility to support operations and growth initiatives.
Average Trading Volume: 1,881,240
Technical Sentiment Signal: Sell
Current Market Cap: $4.14B
For detailed information about OPCH stock, go to TipRanks’ Stock Analysis page.